Core Insights - Avalon GloboCare Corp. has renewed the U.S. FDA establishment registration for the KetoAir™ device, a handheld breathalyzer for ketogenic health management [1][5] - The KetoAir™ device measures breath acetone concentration, providing real-time insights into metabolic state for individuals on ketogenic diets [2][5] - Avalon plans to launch KetoAir™ in both B2B and B2C markets using its Catch-Up™ platform, which is powered by generative AI for marketing and distribution [3][4] Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy and generative AI [5] - The KetoAir™ device is registered as a Class I medical device with the FDA and is intended for weight management, athletic performance, and lifestyle-based ketogenic programs [2][5] - The company is also advancing its intellectual property portfolio through existing patent applications and operates commercial real estate [5]

Core Insights - E.F. Hutton & Co. served as the exclusive financial advisor to RPM Interactive, Inc. in its acquisition by Avalon GloboCare Corp., marking a significant strategic milestone for RPM [1][4] - The transaction was an all-stock merger valued at approximately $19.5 million, with Avalon acquiring RPM's Catch-Up™ Software-as-a-Service platform [2] Company Overview - E.F. Hutton & Co. is a leading investment bank providing strategic advisory and capital markets services, with a focus on innovative, high-growth companies in technology and artificial intelligence sectors [1][6] - The firm has extensive experience in executing complex mergers and acquisitions involving emerging technologies and publicly traded companies [3][6] Transaction Details - RPM merged with Avalon Quantum AI, a wholly owned subsidiary of Avalon GloboCare, acquiring a generative AI video production system designed for creating and distributing digital content [2][4] - The Catch-Up™ platform automates video production, enabling content creators and brands to publish across major digital platforms without manual editing [4] Strategic Implications - Avalon plans to utilize the Catch-Up™ platform to enhance marketing initiatives for its consumer wellness products, aiming to accelerate digital engagement and broaden audience reach [5] - The acquisition positions RPM's technology for expanded deployment, supporting long-term growth and value creation [4][5]

Core Viewpoint - Avalon GloboCare Corp. has acquired RPM Interactive, enhancing its capabilities in generative AI and addressing Nasdaq listing requirements [1][2] Group 1: Acquisition Details - The acquisition of RPM Interactive was executed as an all-stock transaction, resulting in the issuance of 19,500 shares of Series E Non-Voting Convertible Preferred Stock valued at $19.5 million [2] - Each share of Series E Preferred Stock has a stated value of $1,000 and is convertible into common stock at a price of $1.50, subject to certain conditions [2] Group 2: Technology and Product Development - RPM has developed the Catch-Up Software-as-a-Service (SaaS) platform, which automates the creation of short-form video content, including sourcing clips and generating AI commentary [3][4] - The platform is designed for content creators and media companies to produce recap-style videos efficiently, without the need for manual editing or technical expertise [4] Group 3: Strategic Integration - Avalon plans to utilize the Catch-Up platform to enhance marketing efforts for its KetoAir™ product, aiming to increase audience reach and digital engagement [5][6] - The integration of RPM's technology is expected to support Avalon's long-term value creation strategy and broaden its digital marketing capabilities [6] Group 4: Leadership and Expertise - Michael Mathews, CEO of RPM, has been appointed to Avalon's Board of Directors, bringing over two decades of experience in technology and digital media [6][9] - His background includes leadership roles in performance marketing and AI-enabled content systems, which are expected to contribute to Avalon's growth strategy [9] Group 5: Future Plans - Marketing for the Catch-Up platform is set to commence immediately after the new year, indicating a proactive approach to market entry [3] - Avalon is also pursuing a merger with YOOV Group Holdings Limited, which will further enhance its capabilities in AI automation solutions [10]

Core Insights - Avalon GloboCare Corp. announced significant advancements for its KetoAir™ product in Q3 2025, including expanded deployment, a first-responder metabolic health program, and entry into international markets [1][3] Product Development - KetoAir™ is a handheld breathalyzer designed for ketogenic health management, measuring breath acetone concentration (BrAce), which indicates fat metabolism and ketosis [3] - The device is FDA-registered as a Class I medical device and is compatible with both Apple and Android devices, available for purchase through the Apple App Store and Google Play Store [3][5] Market Expansion - Avalon launched the KetoAir™ in the United Kingdom on September 1, 2025, marking its first international expansion [7] - The company showcased KetoAir™ at the London Health Optimization Summit on September 13-14, 2025, highlighting its integration into wellness and metabolic health programs [7] Health Initiatives - In August 2025, Avalon, in collaboration with Saga Health and SpecialtyHealth, launched the "Nevada POOL/PACT Holistic Health Reset" program for 50 first responders, utilizing KetoAir™ for daily monitoring of metabolic changes [7] - Mid-program results from the Nevada initiative indicated individual improvements in metabolic health, potentially driven by better diet, exercise, and sleep quality [7]

Core Viewpoint - Avalon GloboCare Corp. has announced a wholesale distribution agreement with Saga Health Corporation for the KetoAir™ breathalyzer device, aimed at first responders as part of Saga's Holistic Health Reset Program [1][3]. Company Overview - Avalon GloboCare Corp. (NASDAQ: ALBT) specializes in precision diagnostic consumer products and cellular therapy intellectual property [5]. - The company is currently marketing the KetoAir™ breathalyzer, which is registered as a Class I medical device with the U.S. FDA [5]. - Avalon also focuses on advancing its intellectual property portfolio through existing patent applications and operates commercial real estate [5]. Product Details - The KetoAir™ breathalyzer is designed for ketogenic health management, measuring breath acetone concentration (BrAce) to indicate fat metabolism and ketosis [2]. - It is intended for users on ketogenic diets for weight loss, athletic performance, or therapeutic purposes, utilizing nano-sensor technology for real-time insights [2]. - The device is compatible with both Apple and Android devices and is available on the Apple App Store and Google Play Store [2]. Partnership Significance - The agreement with Saga Health is seen as a milestone for accelerating the commercial expansion of the KetoAir™ device [3]. - The collaboration aims to meet the growing demand for personalized, real-time monitoring of BrAce among those pursuing ketogenic lifestyles [3]. - Saga Health's Holistic Health Reset Program provides personalized nutritional guidance and tools like the KetoAir™ breathalyzer to improve participants' health [6].